ICD-11 code : 1D60.0;
Preferred Label : Ebola disease;
ICD-11 definition : A severe disease with high case fatality caused by infection with Ebola virus or a
closely related virus. Ebola disease is typically characterized by acute onset of
fever with non-specific symptoms/signs (e.g., abdominal pain, anorexia, fatigue, malaise,
myalgia, sore throat) usually followed several days later by nausea, vomiting, diarrhea,
and occasionally a variable rash. Hiccups may occur. Severe illness may include hemorrhagic
manifestations (e.g., bleeding from puncture sites, ecchymoses, petechiae, visceral
effusions), encephalopathy, shock/hypotension, multi-organ failure, spontaneous abortion
in infected pregnant women. Common laboratory findings include thrombocytopenia, elevated
transaminase concentrations, electrolyte abnormalities, and signs of renal dysfunction.
Individuals who recover may experience prolonged sequelae (e.g., arthralgia, neurocognitive
dysfunction, uveitis sometimes followed by cataract formation), and clinical and subclinical
persistent infection may occur in immune-privileged compartments (e.g., CNS, eyes,
testes). Person-to-person transmission occurs by direct contact with blood, other
bodily fluids, organs, or contaminated surfaces and materials with risk beginning
at the onset of clinical signs and increasing with disease severity. Family members,
sexual contacts, healthcare providers, and participants in burial ceremonies with
direct contact with the deceased are at particular risk. The incubation period typically
is 7–11 days (range 2–21 days).;
ICD-11 synonym : Ebola haemorrhagic fever; EBOD - [Ebola Disease];
ICD-11 acronym : EBOD;
ICD-11 "other" category code : 1D60.0Y;
ICD-11 "unspecified" category code : 1D60.0Z;
Origin ID : 1517015847;
UMLS CUI : C0282687;
Currated CISMeF NLP mapping
- ebola [MedlinePlus Topic]
ICD-10 Mapping
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
- ebola [MedlinePlus Topic]
Validated automatic mappings to BTNT
A severe disease with high case fatality caused by infection with Ebola virus or a
closely related virus. Ebola disease is typically characterized by acute onset of
fever with non-specific symptoms/signs (e.g., abdominal pain, anorexia, fatigue, malaise,
myalgia, sore throat) usually followed several days later by nausea, vomiting, diarrhea,
and occasionally a variable rash. Hiccups may occur. Severe illness may include hemorrhagic
manifestations (e.g., bleeding from puncture sites, ecchymoses, petechiae, visceral
effusions), encephalopathy, shock/hypotension, multi-organ failure, spontaneous abortion
in infected pregnant women. Common laboratory findings include thrombocytopenia, elevated
transaminase concentrations, electrolyte abnormalities, and signs of renal dysfunction.
Individuals who recover may experience prolonged sequelae (e.g., arthralgia, neurocognitive
dysfunction, uveitis sometimes followed by cataract formation), and clinical and subclinical
persistent infection may occur in immune-privileged compartments (e.g., CNS, eyes,
testes). Person-to-person transmission occurs by direct contact with blood, other
bodily fluids, organs, or contaminated surfaces and materials with risk beginning
at the onset of clinical signs and increasing with disease severity. Family members,
sexual contacts, healthcare providers, and participants in burial ceremonies with
direct contact with the deceased are at particular risk. The incubation period typically
is 7–11 days (range 2–21 days).